InsiderTrades

Form 4 for MRNA Moderna

Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-12 · accession 0001127602-22-011966 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-04-14 2022-04-12+ MRNA Hoge Stephen Pres M - OptEx $5.95 +20.0K 1.64M +1% +$118.9K
DM 2022-04-14 2022-04-12+ MRNA Hoge Stephen Pres S - Sale+OE $158.53 -20.0K 1.62M -1% -$3.17M
DM 2022-04-14 2022-04-12+ MRNA Hoge Stephen Pres M - OptEx $0.00 -20.0K 47.4K -30% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-12 M A 5,000 $10.90 1,627,532 D — —
2 Common Common Stock 2022-04-12 S D 5,000 $159.00 1,622,532 D — —
3 Common Common Stock 2022-04-13 M A 5,000 $10.90 1,627,532 D — —
4 Common Common Stock 2022-04-13 M A 10,000 $0.99 1,637,532 D — —
5 Common Common Stock 2022-04-13 S D 15,000 $158.37 1,622,532 D — —
6 Derivative Stock Option (Right to Buy) 2022-04-12 M D 5,000 $0.00 101,972 D $10.90 · — to 2026-02-23 5,000 Common Stock (F3) This option is fully vested and exercisable.
7 Derivative Stock Option (Right to Buy) 2022-04-13 M D 5,000 $0.00 96,972 D $10.90 · — to 2026-02-23 5,000 Common Stock (F3) This option is fully vested and exercisable.
8 Derivative Stock Option (Right to Buy) 2022-04-13 M D 10,000 $0.00 47,431 D $0.99 · — to 2023-08-19 10,000 Common Stock (F3) This option is fully vested and exercisable.